The table below shows Revolution Medicines, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$0.00
$0.00
$11.58M
$35.38M
$29.39M
$42.98M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$987.33M
$592.23M
$423.14M
$253.07M
$186.95M
$132.25M
SG&A
$195.04M
RVMD annual revenue (10-K history)
Revolution Medicines, Inc. reported annual revenue of $0.00 for fiscal year 2025. Over the 8 fiscal years shown, annual revenue declined from $20.16M (FY 2018) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.